Results 71 to 80 of about 562 (137)

Specific features of neurological complications developing in patients with type 2 diabetes mellitus and metabolic syndrome: Possibility for correction and prevention

open access: yesТерапевтический архив, 2015
The prevalence of type 2 diabetes mellitus (DM) and preceding metabolic disturbances has reached epidemic proportions. Oxidative stress plays a significant role in the development of micro- and macrovascular complications in patients with DM.
V N Shishkova
doaj  

Research of free radical and tissue energy supply processes on rats subjected to concurrent Tetrachlormethane and Adrenaline impact after Mexidol administration [PDF]

open access: yes, 2015
Aleksevych K. O., Fira L. S., Hrymalyuk O. I., Shtroblya A. L. Research of free radical and tissue energy supply processes on rats subjected to concurrent Tetrachlormethane and Adrenaline impact after Mexidol administration.
Oleh Hrymaluck   +7 more
core  

Antihypoxic activity of zinc acetate complexes with N-allenyl- and N-isopropenylimidazoles on hypoxia models of various ethiology

open access: yesСеченовский вестник, 2016
А comparative study of antihypoxic effect of complex compounds of zinc acetate with N-allenyland N-isopropenylimidazole, complexes immobilized on the sulfated arabinogalactan, and well-known antihypoxants, and/or antioxidants: ethomerzol, mexidol and ...
S. A. Shakhmardanova   +6 more
doaj  

Cognitive impairments as a universal clinical syndrome in a therapist's practice

open access: yesТерапевтический архив, 2014
The problem of cognitive dysfunctions in patients with somatic diseases occupies a prominent place now since they are one of the most common manifestations of organic brain lesions. The early detection of potentially cured cognitive impairments is one of
V N Shishkova
doaj  

Metabolic changes on the background of acute exposure to paracetamol and evaluation of the effectiveness of hepatoprotective drugs

open access: yes, 2020
Introduction. In modern conditions, caused by the pandemic of a new type of viral infection Covid 19, the use of paracetamol, which has hepatotoxic properties in overdose, has increased.
Timasheva Gulnara V.
core  

P300 pharmacokinetics and neurochemistry of mexidole

open access: yesEuropean Journal of Pharmaceutical Sciences, 1994
I.I. Miroschnichenko, L.D. Smirnov
openaire   +1 more source

The effect of mexidol on the process of glycolysis in rats under acute stress conditions

open access: yes, 2004
В экспериментах на 29 белых крысах-самцах изучено влияние мексидола (100 мг/кг) на содержание глюкозы, пировиноградной и молочной кислот в головном мозге, печени, селезенке, тимусе и сыворотке крови при остром иммобилизационном стрессе (3 ч).
Девяткина, Татьяна Алексеевна   +8 more
core  

ВЛИЯНИЕ ПРОИЗВОДНОГО 2-БЕНЗАМИД-2(2-ОКСОИНДОЛИН-3-ИЛИДЕН) УКСУСНОЙ КИСЛОТЫ НА АКТИВНОСТЬ СВОБОДНО-РАДИКАЛЬНЫХ ПРОЦЕССОВ ПРИ ЧЕРЕПНО-МОЗГОВОЙ ТРАВМЕ АННОТАЦИЯ

open access: yes, 2016
In experiments on adult laboratory rats investigated the effect of the derivative of 2-benzamido-2-(2-oxoindolin-3-iliden) acetic acid under the symbol ZNM the activity of the lipid and protein peroxidation and antioxidant system in blood plasma and ...
Bukataru, Yu.S.   +2 more
core  

The possibilities of Mexidol usage in neuropediatrics

S.S. Korsakov Journal of Neurology and Psychiatry, 2023
Mexidol (ethylmethylhydroxypyridine succinate) is a modern neurometabolic medication increasingly being used in neuropediatrics. The results of recent studies confirming the positive effects of Mexidol pharmacotherapy in children with attention deficit hyperactivity disorder (ADHD), perinatal damages of the central nervous system (hypoxic-ischemic ...
N.N. Zavadenko   +2 more
openaire   +2 more sources

The efficacy and safety study of Mexidol and Mexidol FORTE 250 in patients with chronic cerebral ischemia

Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 2021
To study the efficacy and safety of sequential MexidoL therapy, administered intravenously (500 mg once a day) for 14 days, followed by taking the oral form Mexidol FORTE 250 at a dose of 250 mg (1 tablet) 3 times a day for 60 days in elderly patients with chronic cerebral ischemia (CCI) on the background of arterial hypertension and atherosclerosis.An
L A, Shchepankevich   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy